Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression

Urology

Volumn 61, Issue 6, 2003, Pages 1187-1192

  Freedland, Stephen J ^b   De Gregorio, Frank ^b   Sacoolidge, John C ^b   Elshimali, Yahya I ^b   Csathy, George S ^b   Elashoff, David A ^b   Reiter, Robert E ^b   Aronson, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; PROSTATE SPECIFIC ANTIGEN; PROTEIN P27;

ADULT; AGED; ANALYSIS; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXAMINATION; FOLLOW UP; HAZARD ASSESSMENT; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; ORGAN; PATIENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATECTOMY; PROTEIN EXPRESSION; RECURRENT DISEASE; SCORING SYSTEM; STAINING; TIME; TUMOR BIOPSY;

EID: 0038277451     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00034-7     Document Type: Article

References (23)

1. Harding M.A., Theodorescu D. Prognostic markers in localized prostate cancer from microscopes to molecules . Cancer Metastasis Rev. 17:1998;429-437.
2. Moul J.W., Kane C.J., Malkowicz S.B. The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy. Urol Clin North Am. 28:2001;459-472.
3. Polyak K., Lee M.H., Erdjument-Bromage H., et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-66.
4. Sgambato A., Cittadini A., Faraglia B., et al. Multiple functions of p27(Kip1) and its alterations in tumor cells a review . J Cell Physiol. 183:2000;18-27.
5. Yang R.M., Naitoh J., Murphy M., et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol. 159:1998;941-945.
6. Cheng L., Lloyd R.V., Weaver A.L., et al. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res. 6:2000;1896-1899.
7. Cote R.J., Shi Y., Groshen S., et al. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst. 90:1998;916-920.
8. Vis A.N., Noordzij M.A., Fitoz K., et al. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. J Urol. 164:2000;2156-2161.
9. Tsihlias J., Kapusta L.R., DeBoer G., et al. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res. 58:1998;542-548.
10. Kuczyk M., Machtens S., Hradil K., et al. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients. Br J Cancer. 81:1999;1052-1058.
11. Freedland SJ, deGregorio F, Sacoolidge JC, et al: Preoperative p27 status is an independent predictor of PSA failure following radical prostatectomy. J Urol 169:1325-1330, 2003.
12. Swanson G., Riggs M., Earle J., et al. Long-term follow-up of radical retropubic prostatectomy for prostate cancer. Eur Urol. 42:2002;212-216.
13. Salomon L., Levrel O., de la Taille A., et al. Radical prostatectomy by the retropubic, perineal and laparoscopic approach 12 years of experience in one center . Eur Urol. 42:2002;104-110.
14. Palisaan R.J., Graefen M., Karakiewicz P.I., et al. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer. Eur Urol. 41:2002;155-161.
15. Powell I.J., Banerjee M., Novallo M., et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 55:2000;246-251.
16. Rauch M.K., Schrage M., Dorey F., et al. Low p27 protein expression independently predicts poor disease free survival in patients with positive surgical margins following radical prostatectomy. J Urol. 161:1999;924.
17. Freedland S.J., Dorey F., Aronson W.J. Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. Urology. 56:2000;807-811.
18. Freedland S.J., Jalkut M., Dorey F., et al. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 56:2000;87-91.
19. Hall G.S., Kramer C.E., Epstein J.I. Evaluation of radical prostatectomy specimens A comparative analysis of sampling methods . Am J Surg Pathol. 16:1992;315-324.
20. Thomas G.V., Schrage M.I., Rosenfelt L., et al. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. J Urol. 164:2000;1987-1991.
21. Vis A.N., van Rhijn B.W., Noordzij M.A., et al. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer. J Pathol. 197:2002;148-154.
22. Elstner E., Campbell M.J., Munker R., et al. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate. 40:1999;141-149.
23. Ikezoe T., Chen S.S., Heber D., et al. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest. Prostate. 49:2001;285-292.